We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Reference Ranges Established for Automated Cerebrospinal Fluid Cell Count

By LabMedica International staff writers
Posted on 11 Feb 2014
Cerebrospinal fluid (CSF) cell count is an important analysis in the investigation of central nervous system (CNS) infections, and new reference ranges for leukocytes in the CSF have been established. More...


The references ranges for granulocytes, lymphocytes, and monocytes in the CSF were originally based on manual counts, but since the introduction of automated cell counters, these ranges have not been revised, or abnormalities connected to diseases.

Infectious disease specialists at the Sahlgrenska Academy (Gothenburg, Sweden) analyzed CSF from 80 neurologically healthy volunteers. For the differential diagnosis section, they analyzed cell counts and hospital records from 175 patients with CSF mononuclear pleocytosis, which is an increased cell count particularly an increase in white blood cell (WBC) count, in a bodily fluid, such as CSF.

Manual CSF cell counting was performed and compared with automated CSF cell counting was performed on a ADVIA 2120i instrument within one hour of sampling using the ADVIA 2120i CSF Assay (Siemens, Erlangen, Germany). The method requires 300 μL of CSF and reports counts for erythrocytes, lymphocytes, monocytes and granulocytes, which are differentiated on the basis of size, absorbance and light scattering characteristics.

Correlation between manual and automated cell counts was excellent for erythrocytes, but was lower for leukocytes, when erythrocyte counts were lower than 250 cells/μL. For the neurologically healthy volunteers studied in the reference range section, the 95th percentile was 3.0 cells/μL for lymphocytes, 1.0 cell/μL for monocytes, and 1.0 cell/μL for granulocytes. In the differential diagnosis section, comparisons were done between the groups with Lyme neuroborreliosis and viral CNS infection. There were no significant differences between these two groups regarding cell counts; neither for lymphocytes, median 58 cells/μL vs. 72 cells/μL; nor for monocytes, median 13 cells/μL vs. 16 cells/μL; nor for granulocytes, median 1 cell/μL vs. 2 cells/μL.

The authors suggested that new reference ranges of less than 4 cells/μL for lymphocytes, less than 3 cells/μL for monocytes, and less than 3 cells/μL for granulocytes for CSF leukocytes when automatically analyzed with the Siemens ADVIA 2120i. The separation of mononuclear cells into lymphocytes and monocytes did not facilitate the discrimination between Lyme neuroborreliosis and viral CNS infection. The study was published in the January 2014 issue of the journal Clinical Biochemistry.

Related Links:

Sahlgrenska Academy
Siemens 



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Blood Ammonia Test Analyzer
DRI-CHEM NX10N
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.